Please Wait.....
Report
Alcohol Dehydrogenase Market? By Type (Medium-chain Enzymes, Short-chain Enzymes) , By Application (Alcohol Concentration Detection, Disease Diagnosis, Catalyst) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 216 Pages I Allied Market Research
The alcohol dehydrogenase market was valued at $0.6 billion in 2023, and is projected to reach $1.1 billion by 2033, growing at a CAGR of 6.5% from 2024 to 2033.
Alcohol dehydrogenase is class of zinc-containing enzyme that is majorly responsible for the oxidation of alcohols to aldehydes or ketones. This enzyme is predominantly synthesized liver and stomach of humans that acts as a primary defense against a toxic molecule, alcohol. Alcohol dehydrogenase detoxifies this potentially harmful molecule into a mere foodstuff, thereby playing a critical role in preventing the accumulation of toxic levels and eliminating alcohol from the body.
The growth of the global alcohol dehydrogenase market is majorly driven by rise in global alcohol consumption and alarming increase in prevalence of alcohol-related diseases. This is attributed to the fact that alcohol dehydrogenase mitigates the intoxicating effects of alcohol and facilitates its excretion from the body. According to the World Health Organization, alcohol is an established carcinogen and is known to increase the risk of cancer. Approximately 401,000 cancer deaths were registered in 2019 due to alcohol consumption. In addition, rise in awareness about alcohol-related health issues and the need for effective diagnostic tools and treatments boosts the demand for alcohol dehydrogenase. Moreover, increase in adoption of alcohol dehydrogenase in green chemistry notably contributes toward the growth of the market. However, high production cost of alcohol dehydrogenase restrains the growth of the market. Furthermore, the complexity associated with the production process and the need for advanced technology and skilled technicians incur additional costs, which further restrict the market growth. On the contrary, advances in diagnostic technologies, such as more accurate and efficient assays for measuring alcohol dehydrogenase activity, are expected to offer remunerative opportunities for the market growth during the forecast period. Furthermore, technological innovations in biotechnology and enzyme engineering contribute to the development of new alcohol dehydrogenase products and applications, including recombinant alcohol dehydrogenase enzymes and improved diagnostic assays, which are anticipated to open new avenues for the expansion of the market.
The alcohol dehydrogenase industry is segmented into type, application, and region. On the basis of type, the market is bifurcated into medium-chain enzymes and short-chain enzymes. On the basis of application, the market is segregated into alcohol concentration detection, disease diagnosis, and catalyst. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By type, the medium-chain segment dominated the market in 2023.
On the basis of application, the alcohol concentration detection segment held a major share of the market in 2023.
Region wise, North America exhibited the highest growth in 2023.
Competition Analysis
Competitive analysis and profiles of the major players in the global alcohol dehydrogenase market include Sigma-Aldrich, Thermo Fisher Scientific, BioVision Inc., Creative Enzymes Technologies, LLC, MP Biomedicals, Randox Laboratories Limited, Sekisui Diagnostics, Prospec-Tany Technogene Ltd., Roche Diagnostics, and Worthington Biochemical Corporation These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Historic market data
- Reimbursement Scenario
Key Market Segments
By Type
- Medium-chain Enzymes
- Short-chain Enzymes
By Application
- Alcohol Concentration Detection
- Disease Diagnosis
- Catalyst
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- Key Market Players
- Sigma-Aldrich
- Thermo Fisher Scientific Inc.
- BioVision Inc.
- Creative Enzymes Technologies, LLC
- MP Biomedicals
- Randox Laboratories Limited
- Sekisui Diagnostics
- Prospec-Tany Technogene Ltd.
- Roche Diagnostics
- Worthington Biochemical Corp.
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Center Type
4.2. Single Specialty Centers
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Multispecialty Centers
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: AMBULATORY SURGERY CENTER MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Gastroenterology
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Ophthalmology
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Orthopedics
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Neurology
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Others
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
CHAPTER 6: AMBULATORY SURGERY CENTER MARKET, BY MODALITY
6.1. Market Overview
6.1.1 Market Size and Forecast, By Modality
6.2. Hospital Based Ambulatory Surgical Center
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Freestanding Ambulatory Surgical Center
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
CHAPTER 7: AMBULATORY SURGERY CENTER MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Center Type
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By Modality
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Ambulatory Surgery Center Market
7.2.6.1. Market Size and Forecast, By Center Type
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By Modality
7.2.7. Canada Ambulatory Surgery Center Market
7.2.7.1. Market Size and Forecast, By Center Type
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By Modality
7.2.8. Mexico Ambulatory Surgery Center Market
7.2.8.1. Market Size and Forecast, By Center Type
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By Modality
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Center Type
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By Modality
7.3.5. Market Size and Forecast, By Country
7.3.6. France Ambulatory Surgery Center Market
7.3.6.1. Market Size and Forecast, By Center Type
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By Modality
7.3.7. Germany Ambulatory Surgery Center Market
7.3.7.1. Market Size and Forecast, By Center Type
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By Modality
7.3.8. Italy Ambulatory Surgery Center Market
7.3.8.1. Market Size and Forecast, By Center Type
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By Modality
7.3.9. Spain Ambulatory Surgery Center Market
7.3.9.1. Market Size and Forecast, By Center Type
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By Modality
7.3.10. UK Ambulatory Surgery Center Market
7.3.10.1. Market Size and Forecast, By Center Type
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By Modality
7.3.11. Rest of Europe Ambulatory Surgery Center Market
7.3.11.1. Market Size and Forecast, By Center Type
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By Modality
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Center Type
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By Modality
7.4.5. Market Size and Forecast, By Country
7.4.6. China Ambulatory Surgery Center Market
7.4.6.1. Market Size and Forecast, By Center Type
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By Modality
7.4.7. Japan Ambulatory Surgery Center Market
7.4.7.1. Market Size and Forecast, By Center Type
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By Modality
7.4.8. India Ambulatory Surgery Center Market
7.4.8.1. Market Size and Forecast, By Center Type
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By Modality
7.4.9. South Korea Ambulatory Surgery Center Market
7.4.9.1. Market Size and Forecast, By Center Type
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By Modality
7.4.10. Australia Ambulatory Surgery Center Market
7.4.10.1. Market Size and Forecast, By Center Type
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By Modality
7.4.11. Rest of Asia-Pacific Ambulatory Surgery Center Market
7.4.11.1. Market Size and Forecast, By Center Type
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By Modality
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Center Type
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By Modality
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Ambulatory Surgery Center Market
7.5.6.1. Market Size and Forecast, By Center Type
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By Modality
7.5.7. South Africa Ambulatory Surgery Center Market
7.5.7.1. Market Size and Forecast, By Center Type
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By Modality
7.5.8. Saudi Arabia Ambulatory Surgery Center Market
7.5.8.1. Market Size and Forecast, By Center Type
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By Modality
7.5.9. Rest of LAMEA Ambulatory Surgery Center Market
7.5.9.1. Market Size and Forecast, By Center Type
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By Modality
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. CHSPSC, LLC
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Edward-Elmhurst Health
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Envision Healthcare Corporation
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Healthway Medical Group
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Nexus Day Surgery Centre
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Pediatrix Medical Group
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Prospect Medical Holdings, Inc.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Surgery Partners
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. SurgCenter
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. TH Medical
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 2. ALCOHOL DEHYDROGENASE MARKET FOR MEDIUM-CHAIN ENZYMES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. ALCOHOL DEHYDROGENASE MARKET FOR SHORT-CHAIN ENZYMES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 5. ALCOHOL DEHYDROGENASE MARKET FOR ALCOHOL CONCENTRATION DETECTION, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. ALCOHOL DEHYDROGENASE MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. ALCOHOL DEHYDROGENASE MARKET FOR CATALYST, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. ALCOHOL DEHYDROGENASE MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. NORTH AMERICA ALCOHOL DEHYDROGENASE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 10. NORTH AMERICA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 11. NORTH AMERICA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 12. U.S. ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 13. U.S. ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 14. CANADA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 15. CANADA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 16. MEXICO ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 17. MEXICO ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 18. EUROPE ALCOHOL DEHYDROGENASE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 19. EUROPE ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 20. EUROPE ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 21. FRANCE ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 22. FRANCE ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 23. GERMANY ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 24. GERMANY ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 25. ITALY ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 26. ITALY ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 27. SPAIN ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 28. SPAIN ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 29. UK ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 30. UK ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 31. REST OF EUROPE ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 32. REST OF EUROPE ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 33. ASIA-PACIFIC ALCOHOL DEHYDROGENASE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 34. ASIA-PACIFIC ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 35. ASIA-PACIFIC ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 36. CHINA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 37. CHINA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 38. JAPAN ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 39. JAPAN ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 40. INDIA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 41. INDIA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 42. SOUTH KOREA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 43. SOUTH KOREA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 44. AUSTRALIA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 45. AUSTRALIA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 46. REST OF ASIA-PACIFIC ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 47. REST OF ASIA-PACIFIC ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 48. LAMEA ALCOHOL DEHYDROGENASE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 49. LAMEA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 50. LAMEA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 51. BRAZIL ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 52. BRAZIL ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 53. SOUTH AFRICA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 54. SOUTH AFRICA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 55. SAUDI ARABIA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 56. SAUDI ARABIA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 57. REST OF LAMEA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 58. REST OF LAMEA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 59. SIGMA-ALDRICH: KEY EXECUTIVES
TABLE 60. SIGMA-ALDRICH: COMPANY SNAPSHOT
TABLE 61. SIGMA-ALDRICH: OPERATING SEGMENTS
TABLE 62. SIGMA-ALDRICH: PRODUCT PORTFOLIO
TABLE 63. SIGMA-ALDRICH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 64. THERMO FISHER SCIENTIFIC: KEY EXECUTIVES
TABLE 65. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 66. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 67. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 68. THERMO FISHER SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 69. BIOVISION INC.: KEY EXECUTIVES
TABLE 70. BIOVISION INC.: COMPANY SNAPSHOT
TABLE 71. BIOVISION INC.: OPERATING SEGMENTS
TABLE 72. BIOVISION INC.: PRODUCT PORTFOLIO
TABLE 73. BIOVISION INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 74. CREATIVE ENZYMES TECHNOLOGIES, LLC: KEY EXECUTIVES
TABLE 75. CREATIVE ENZYMES TECHNOLOGIES, LLC: COMPANY SNAPSHOT
TABLE 76. CREATIVE ENZYMES TECHNOLOGIES, LLC: OPERATING SEGMENTS
TABLE 77. CREATIVE ENZYMES TECHNOLOGIES, LLC: PRODUCT PORTFOLIO
TABLE 78. CREATIVE ENZYMES TECHNOLOGIES, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 79. MP BIOMEDICALS: KEY EXECUTIVES
TABLE 80. MP BIOMEDICALS: COMPANY SNAPSHOT
TABLE 81. MP BIOMEDICALS: OPERATING SEGMENTS
TABLE 82. MP BIOMEDICALS: PRODUCT PORTFOLIO
TABLE 83. MP BIOMEDICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 84. RANDOX LABORATORIES LIMITED: KEY EXECUTIVES
TABLE 85. RANDOX LABORATORIES LIMITED: COMPANY SNAPSHOT
TABLE 86. RANDOX LABORATORIES LIMITED: OPERATING SEGMENTS
TABLE 87. RANDOX LABORATORIES LIMITED: PRODUCT PORTFOLIO
TABLE 88. RANDOX LABORATORIES LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 89. SEKISUI DIAGNOSTICS: KEY EXECUTIVES
TABLE 90. SEKISUI DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 91. SEKISUI DIAGNOSTICS: OPERATING SEGMENTS
TABLE 92. SEKISUI DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 93. SEKISUI DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 94. PROSPEC-TANY TECHNOGENE LTD.: KEY EXECUTIVES
TABLE 95. PROSPEC-TANY TECHNOGENE LTD.: COMPANY SNAPSHOT
TABLE 96. PROSPEC-TANY TECHNOGENE LTD.: OPERATING SEGMENTS
TABLE 97. PROSPEC-TANY TECHNOGENE LTD.: PRODUCT PORTFOLIO
TABLE 98. PROSPEC-TANY TECHNOGENE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99. ROCHE DIAGNOSTICS: KEY EXECUTIVES
TABLE 100. ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 101. ROCHE DIAGNOSTICS: OPERATING SEGMENTS
TABLE 102. ROCHE DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 103. ROCHE DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104. WORTHINGTON BIOCHEMICAL CORP.: KEY EXECUTIVES
TABLE 105. WORTHINGTON BIOCHEMICAL CORP.: COMPANY SNAPSHOT
TABLE 106. WORTHINGTON BIOCHEMICAL CORP.: OPERATING SEGMENTS
TABLE 107. WORTHINGTON BIOCHEMICAL CORP.: PRODUCT PORTFOLIO
TABLE 108. WORTHINGTON BIOCHEMICAL CORP.: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL ALCOHOL DEHYDROGENASE MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF ALCOHOL DEHYDROGENASE MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN ALCOHOL DEHYDROGENASE MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALALCOHOL DEHYDROGENASE MARKET
FIGURE 10. GLOBAL ALCOHOL DEHYDROGENASE MARKET SEGMENTATION, BY TYPE
FIGURE 11. ALCOHOL DEHYDROGENASE MARKET FOR MEDIUM-CHAIN ENZYMES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. ALCOHOL DEHYDROGENASE MARKET FOR SHORT-CHAIN ENZYMES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL ALCOHOL DEHYDROGENASE MARKET SEGMENTATION, BY APPLICATION
FIGURE 14. ALCOHOL DEHYDROGENASE MARKET FOR ALCOHOL CONCENTRATION DETECTION, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. ALCOHOL DEHYDROGENASE MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. ALCOHOL DEHYDROGENASE MARKET FOR CATALYST, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 18. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 19. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 20. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 21. COMPETITIVE DASHBOARD
FIGURE 22. COMPETITIVE HEATMAP: ALCOHOL DEHYDROGENASE MARKET
FIGURE 23. TOP PLAYER POSITIONING, 2023
FIGURE 24. SIGMA-ALDRICH: NET SALES, 2021-2023 ($BILLION)
FIGURE 25. SIGMA-ALDRICH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 26. SIGMA-ALDRICH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 27. THERMO FISHER SCIENTIFIC: NET SALES, 2021-2023 ($BILLION)
FIGURE 28. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. BIOVISION INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 31. BIOVISION INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. BIOVISION INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. CREATIVE ENZYMES TECHNOLOGIES, LLC: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. CREATIVE ENZYMES TECHNOLOGIES, LLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. CREATIVE ENZYMES TECHNOLOGIES, LLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. MP BIOMEDICALS: NET SALES, 2021-2023 ($BILLION)
FIGURE 37. MP BIOMEDICALS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. MP BIOMEDICALS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. RANDOX LABORATORIES LIMITED: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. RANDOX LABORATORIES LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. RANDOX LABORATORIES LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. SEKISUI DIAGNOSTICS: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. SEKISUI DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. SEKISUI DIAGNOSTICS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. PROSPEC-TANY TECHNOGENE LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. PROSPEC-TANY TECHNOGENE LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. PROSPEC-TANY TECHNOGENE LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. ROCHE DIAGNOSTICS: NET SALES, 2021-2023 ($BILLION)
FIGURE 49. ROCHE DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. ROCHE DIAGNOSTICS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. WORTHINGTON BIOCHEMICAL CORP.: NET SALES, 2021-2023 ($BILLION)
FIGURE 52. WORTHINGTON BIOCHEMICAL CORP.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. WORTHINGTON BIOCHEMICAL CORP.: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security